These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 1306098)
1. Epidemiological models of carcinogenesis: the example of bladder cancer. Vineis P Cancer Epidemiol Biomarkers Prev; 1992; 1(2):149-53. PubMed ID: 1306098 [TBL] [Abstract][Full Text] [Related]
2. Molecular epidemiology of bladder cancer. Vineis P; Martone T Ann Ist Super Sanita; 1996; 32(1):21-7. PubMed ID: 8967722 [TBL] [Abstract][Full Text] [Related]
3. Acetylation phenotype, carcinogen-hemoglobin adducts, and cigarette smoking. Vineis P; Caporaso N; Tannenbaum SR; Skipper PL; Glogowski J; Bartsch H; Coda M; Talaska G; Kadlubar F Cancer Res; 1990 May; 50(10):3002-4. PubMed ID: 2334904 [TBL] [Abstract][Full Text] [Related]
4. N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels. Probst-Hensch NM; Bell DA; Watson MA; Skipper PL; Tannenbaum SR; Chan KK; Ross RK; Yu MC Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):619-23. PubMed ID: 10868698 [TBL] [Abstract][Full Text] [Related]
5. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels. Landi MT; Zocchetti C; Bernucci I; Kadlubar FF; Tannenbaum S; Skipper P; Bartsch H; Malaveille C; Shields P; Caporaso NE; Vineis P Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):693-8. PubMed ID: 8877060 [TBL] [Abstract][Full Text] [Related]
6. Black (air-cured) and blond (flue-cured) tobacco cancer risk. IV: Molecular dosimetry studies implicate aromatic amines as bladder carcinogens. Bartsch H; Malaveille C; Friesen M; Kadlubar FF; Vineis P Eur J Cancer; 1993; 29A(8):1199-207. PubMed ID: 8518034 [TBL] [Abstract][Full Text] [Related]
7. Nonsmoking-related arylamine exposure and bladder cancer risk. Skipper PL; Tannenbaum SR; Ross RK; Yu MC Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):503-7. PubMed ID: 12814994 [TBL] [Abstract][Full Text] [Related]
8. Cytochrome P-450 and acetyltransferase expression as biomarkers of carcinogen-DNA adduct levels and human cancer susceptibility. Badawi AF; Stern SJ; Lang NP; Kadlubar FF Prog Clin Biol Res; 1996; 395():109-40. PubMed ID: 8895986 [TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy. Shen M; Hung RJ; Brennan P; Malaveille C; Donato F; Placidi D; Carta A; Hautefeuille A; Boffetta P; Porru S Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1234-40. PubMed ID: 14652287 [TBL] [Abstract][Full Text] [Related]
10. Analysis of DNA adducts in smokers' lung and urothelium by 32P-postlabelling: metabolic phenotype dependence and comparisons with other exposure markers. Bartsch H; Castegnaro M; Camus AM; Schouft A; Geneste O; Rojas M; Alexandrov K IARC Sci Publ; 1993; (124):331-40. PubMed ID: 8225503 [TBL] [Abstract][Full Text] [Related]
11. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking. Okkels H; Sigsgaard T; Wolf H; Autrup H Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426 [TBL] [Abstract][Full Text] [Related]
12. Effects of timing and type of tobacco in cigarette-induced bladder cancer. Vineis P; Esteve J; Hartge P; Hoover R; Silverman DT; Terracini B Cancer Res; 1988 Jul; 48(13):3849-52. PubMed ID: 3378220 [TBL] [Abstract][Full Text] [Related]
13. Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction. Marcus PM; Hayes RB; Vineis P; Garcia-Closas M; Caporaso NE; Autrup H; Branch RA; Brockmöller J; Ishizaki T; Karakaya AE; Ladero JM; Mommsen S; Okkels H; Romkes M; Roots I; Rothman N Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):461-7. PubMed ID: 10815690 [TBL] [Abstract][Full Text] [Related]
14. Tobacco smoking and risk of bladder cancer. Boffetta P Scand J Urol Nephrol Suppl; 2008 Sep; (218):45-54. PubMed ID: 18815916 [TBL] [Abstract][Full Text] [Related]
15. Genotoxicity of tobacco smoke-derived aromatic amines and bladder cancer: current state of knowledge and future research directions. Besaratinia A; Tommasi S FASEB J; 2013 Jun; 27(6):2090-100. PubMed ID: 23449930 [TBL] [Abstract][Full Text] [Related]
16. Haemoglobin adducts of aromatic amines in people exposed to cigarette smoke. Bryant MS; Vineis P; Skipper PL; Tannenbaum SR IARC Sci Publ; 1988; (89):133-6. PubMed ID: 3198197 [TBL] [Abstract][Full Text] [Related]
17. [Individual susceptibility to occupational carcinogens: the evidence from biomonitoring and molecular epidemiology studies]. Pavanello S; Clonfero E G Ital Med Lav Ergon; 2004; 26(4):311-21. PubMed ID: 15584438 [TBL] [Abstract][Full Text] [Related]
18. Aromatic amines and human urinary bladder cancer: exposure sources and epidemiology. Talaska G J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2003 May; 21(1):29-43. PubMed ID: 12826031 [TBL] [Abstract][Full Text] [Related]
19. [Acetylation phenotype as a biomarker of sensitivity to the carcinogenic effect of aromatic amines]. Indulski JA; Krajewska B; Lutz W Med Pr; 1992; 43(5):427-35. PubMed ID: 1293477 [TBL] [Abstract][Full Text] [Related]
20. Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County. Jiang X; Yuan JM; Skipper PL; Tannenbaum SR; Yu MC Cancer Res; 2007 Aug; 67(15):7540-5. PubMed ID: 17671226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]